Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106130703 | 10613070 | 3 | F | 20131021 | 20160324 | 20141128 | 20160331 | EXP | US-AMGEN-USASP2014091474 | AMGEN | 55.00 | YR | A | F | Y | 0.00000 | 20160331 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106130703 | 10613070 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 106130703 | 10613070 | 2 | SS | ENBREL | ETANERCEPT | 1 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||||
| 106130703 | 10613070 | 3 | SS | ENBREL | ETANERCEPT | 1 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||||
| 106130703 | 10613070 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106130703 | 10613070 | 1 | Ankylosing spondylitis |
| 106130703 | 10613070 | 2 | Arthritis |
| 106130703 | 10613070 | 3 | Fibromyalgia |
| 106130703 | 10613070 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106130703 | 10613070 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106130703 | 10613070 | Alopecia | |
| 106130703 | 10613070 | Ankylosing spondylitis | |
| 106130703 | 10613070 | Carpal tunnel syndrome | |
| 106130703 | 10613070 | Cough | |
| 106130703 | 10613070 | Drug ineffective | |
| 106130703 | 10613070 | Grip strength decreased | |
| 106130703 | 10613070 | Hypersensitivity | |
| 106130703 | 10613070 | Immunodeficiency | |
| 106130703 | 10613070 | Inflammation | |
| 106130703 | 10613070 | Injection site swelling | |
| 106130703 | 10613070 | Injection site urticaria | |
| 106130703 | 10613070 | Joint destruction | |
| 106130703 | 10613070 | Mobility decreased | |
| 106130703 | 10613070 | Muscle spasms | |
| 106130703 | 10613070 | Rhinorrhoea | |
| 106130703 | 10613070 | Sputum discoloured | |
| 106130703 | 10613070 | Thyroid disorder | |
| 106130703 | 10613070 | White blood cell count abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106130703 | 10613070 | 1 | 201308 | 0 |